"Antibodies, Viral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunoglobulins produced in response to VIRAL ANTIGENS.
| Descriptor ID |
D000914
|
| MeSH Number(s) |
D12.776.124.486.485.114.254 D12.776.124.790.651.114.254 D12.776.377.715.548.114.254
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibodies, Viral".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Viral".
This graph shows the total number of publications written about "Antibodies, Viral" by people in this website by year, and whether "Antibodies, Viral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 6 | 6 | 12 |
| 1997 | 2 | 5 | 7 |
| 1998 | 3 | 9 | 12 |
| 1999 | 5 | 7 | 12 |
| 2000 | 2 | 5 | 7 |
| 2001 | 4 | 7 | 11 |
| 2002 | 5 | 13 | 18 |
| 2003 | 4 | 8 | 12 |
| 2004 | 2 | 8 | 10 |
| 2005 | 5 | 11 | 16 |
| 2006 | 2 | 3 | 5 |
| 2007 | 1 | 6 | 7 |
| 2008 | 6 | 12 | 18 |
| 2009 | 5 | 8 | 13 |
| 2010 | 2 | 7 | 9 |
| 2011 | 6 | 13 | 19 |
| 2012 | 10 | 12 | 22 |
| 2013 | 14 | 7 | 21 |
| 2014 | 13 | 13 | 26 |
| 2015 | 21 | 10 | 31 |
| 2016 | 14 | 17 | 31 |
| 2017 | 14 | 15 | 29 |
| 2018 | 19 | 14 | 33 |
| 2019 | 13 | 11 | 24 |
| 2020 | 24 | 18 | 42 |
| 2021 | 29 | 33 | 62 |
| 2022 | 7 | 60 | 67 |
| 2023 | 5 | 48 | 53 |
| 2024 | 28 | 15 | 43 |
| 2025 | 23 | 16 | 39 |
| 2026 | 11 | 8 | 19 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antibodies, Viral" by people in Profiles.
-
Evaluation of a multiantigen mRNA vaccine against EEHV1A in Asian elephants. J Virol. 2026 Aug 18; 100(8):e0038826.
-
First evidence of clinical protection from an EEHV1A mRNA vaccine in naturally infected juvenile elephants. J Virol. 2026 Aug 18; 100(8):e0218625.
-
A distinct E dimer epitope underlies selective recognition by a protective human West Nile virus antibody. EMBO Rep. 2026 Aug; 27(15):4583-4601.
-
The relationship between psychological stress and SARS-CoV-2 nucleocapsid-antibody response following natural infection: longitudinal findings from the Aegis study. Am J Epidemiol. 2026 06 03; 195(6):1624-1633.
-
Maternal RSV Vaccination, Infant Nirsevimab, or Both: Interim Analysis of a Randomized Trial. Pediatrics. 2026 Jun 01; 157(6).
-
Variability in the TLR3 type I interferon pathway is predictive of RNA vaccine responses. Sci Adv. 2026 May 15; 12(20):eaed8930.
-
Asymmetric structural transitions in the icosahedral organization of Eastern equine encephalitis virus. Nat Commun. 2026 May 15; 17(1).
-
Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases. JAMA Neurol. 2026 May 01; 83(5):461-470.
-
Investigating antibody cross-reactivity and transmission dynamics of alphaviruses and flaviviruses using a multiplex serological assay. Nat Commun. 2026 Apr 15; 17(1).
-
Human antibody targeting Crimean-Congo hemorrhagic fever virus glycoprotein 38 protects mice against heterologous virus challenge. J Clin Invest. 2026 May 15; 136(10).